Protalix BioTherapeutics (NYSE:PLX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Thursday. Several other analysts also recently commented on the stock. TheStreet upgraded shares of Protalix BioTherapeutics from a “d-” rating to a “c-” rating in a […]
Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) – Stock analysts at HC Wainwright boosted their FY2023 EPS estimates for shares of Protalix BioTherapeutics in a note issued to investors on Tuesday, November 14th. HC Wainwright analyst R. Selvaraju now expects that the company will earn $0.16 per share for the year, up from their prior […]
Operator: Good morning, ladies and gentlemen. And welcome to the Protalix Biotherapeutics Third Quarter 2023 Financial and Business Results Conference Call.
Protalix Biotherapeutics Reports Third Quarter 2023 Financial And Business Results menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
The Dow Jones closed lower by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.